A warm welcome to Brooke Witherspoon to the position of senior manager on the Endpoint Outcomes team. Brooke will be responsible for conducting qualitative research studies to develop clinical outcome assessments to be used as novel endpoints in clinical trials to support labeling claims. In addition to conducting qualitative research, Brooke has experience developing FDA and EMA dossiers, attending FDA meetings, and navigating the FDA’s Drug Development Tool Qualification process. Brooke has worked across a variety of therapeutic areas including gastroenterology, dermatology, and neurology. Previously, Brooke worked at Ironwood Pharmaceuticals and was responsible for developing and implementing the PRO strategy in primarily gastrointestinal diseases.  In addition to industry work, Brooke held various positions, including Research Manager, at Adelphi (Mapi) Values where she developed study protocols, performed literature reviews, conducted patient interviews, analyzed qualitative data, developed reports and wrote regulatory dossiers.  Brooke received a Bachelor of Arts in Psychology from Bates College in Lewiston, Maine.